Gilead, Kite to Acquire Cell Design Labs for Up-to-$567M, Growing CAR-T Footprint

Gilead, Kite to Acquire Cell Design Labs for Up-to-$567M, Growing CAR-T Footprint

Gilead reasons that the companies could treat a broader range of blood and solid cancers.

Carmot and Amgen to identify new therapeutics for Parkinson’s

Carmot and Amgen to identify new therapeutics for Parkinson’s

The firms will leverage Carmot’s Chemotype Evolution lead-identification technology.

Concentric Analgesics Receives FDA Fast Track Designation for CA-008 for Post-Surgical Pain

 Concentric Analgesics Receives FDA Fast Track Designation for CA-008 for Post-Surgical Pain

Novel prodrug with unique mechanism of action takes on the opioid crisis

Asilomar Bio Raises $12m Series B for Chemical Yield Enhancer

Asilomar Bio Raises $12m Series B for Chemical Yield Enhancer

Asilomar's technology makes plants more efficient at drawing water from the soil.

Siluria Technologies and Wood Launch Technology to Offgas into Refinery Products

Siluria Technologies and Wood Launch Technology to Offgas into Refinery Products

Modus is a modular 'drop in' technology to monetize refinery offgas streams.

Graphwear Takes on Sweat: the Final Frontier for Diagnostics

Graphwear Takes on Sweat: the Final Frontier for Diagnostics

Graphwear's wearable device employs an ultrathin layer of graphene in its sensor.

Shark Tank Billionaire Mark Cuban Invests in Tiny Bay Area Biotech Perlara

Shark Tank Billionaire Mark Cuban Invests in Tiny Bay Area Biotech Perlara

Mark Cuban and Perlara founder Ethan Perlstein met on Twitter, where they had a conversation about drug pricing.

QB3 partners with Science Exchange

QB3 partners with Science Exchange

Bringing 2,500 qualified service providers to our startups through a single access point.

Alector, Abbvie partner on therapies for Alzheimer's

Alector, Abbvie partner on therapies for Alzheimer's

The collaboration could generate up to $225 million for Alector.

Lygos Partners with Agile BioFoundry and DOE

Lygos Partners with Agile BioFoundry and DOE

Lygos’ pilot collaboration is part of a two-year, $5 million, multi-company effort coordinated by the Agile BioFoundry.